Perrigo reports Q4 EPS 77c vs. 93c last year

Reports Q4 revenue $1.11B, vs. $1.14B last year. Organic net sales declined 4.5%, driven primarily by headwinds in the infant formula business, lower OTC contract manufacturing, and soft total OTC category consumption. “Fiscal year 2025 was a pivotal year for Perrigo (PRGO). Despite soft category consumption and a challenging Infant Formula end-market, we gained share across store brands and in key brands as our team executed with discipline,” said CEO Patrick Lockwood-Taylor.